Baird William D III 4
4 · 2seventy bio, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Baird William D III
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-01-06+264,000→ 1,126,126 total - Award
Stock Option (Right to buy)
2025-01-06+176,000→ 176,000 totalExercise: $2.64Exp: 2035-01-06→ Common Stock (176,000 underlying)
Footnotes (2)
- [F1]This restricted stock unit award vests ratably over a four-year period in annual installments with the first installment vesting on January 2, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]This stock option vests over a four-year period at the rate of 25% on January 2, 2026, and then in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.